Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2171 plus FOLFOX in Japanese patients with metastatic colorectal cancer
jRCT2080220420Phase 2
- Sponsor
- AstraZeneca
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cediranib in metastatic colon cancer (mCRC) (3 arms), sponsored by AstraZeneca.
02
Drugs
cediranib
03
Conditions
metastatic colon cancer (mCRC)
Beyond the preview
Go deeper on jRCT2080220420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220420.